Table 1.
Tumor characteristics of 352 invasive breast cancer patients.
| N. (%) | |
|---|---|
| Age (years): median value (range, IQR) | 53 (29-80, 46-63) |
| ≤53 | 182 (51.7) |
| >53 | 170 (48.3) |
| Histotype | |
| IDC | 315 (90.0) |
| ILC | 21 (6.0) |
| Other | 14 (4.0) |
| unknown | 2 |
| Tumor size (cm) | |
| ≤2.0 | 178 (51.3) |
| >2.0 | 169 (48.7) |
| Unknown | 5 |
| Node | |
| Negative | 208 (59.6) |
| Positive | 141 (40.4) |
| unknown | 3 |
| Grade | |
| 1 | 13 (3.7) |
| 2 | 137 (39.3) |
| 3 | 199 (57.0) |
| unknown | 3 |
| ER (%) | |
| ≤10 | 147 (41.9) |
| >10 | 204 (58.1) |
| unknown | 1 |
| PgR (%) | |
| ≤10 | 185 (52.7) |
| >10 | 166 (47.3) |
| unknown | 1 |
| Ki67 (%) | |
| ≤20 | 141 (40.5) |
| >20 | 207 (59.5) |
| unknown | 4 |
| HER2 | |
| Negative | 289 (83.3) |
| Positive | 58 (16.7) |
| unknown | 5 |
| TNBC | |
| No | 237 (68.3) |
| Yes | 110 (31.7) |
| NLRP3 | |
| Negative (<80%) | 227 (68.2) |
| Positive (≥80%) | 106 (31.8) |
| unknown | 19 |
| PYCARD | |
| Negative (<20%) | 205 (61.4) |
| Positive (≥20%) | 129 (38.6) |
| unknown | 18 |
| TLR4 | |
| Negative (<20%) | 208 (64.4) |
| Positive (≥20%) | 115 (35.6) |
| Unknown | 29 |
IQR, interquartile range; IDC, Invasive ductal carcinoma; ILC, Invasive lobular carcinoma; ER, Estrogen receptor; PR, Progesterone receptor; HER2/neu, Human epidermal growth factor receptor 2; NLRP3, NOD-like receptor protein 3; PYCARD, Apoptosis-Associated Speck-Like Protein Containing a Pyrin and CARD domain; TLR4, Toll-like receptor 4; TNBC, triple negative breast cancer.